B+
Bull case
25%
Probability
Target price
$16.50
Analysis reference price unavailable
Analysis 2026-09-08 · RankAlpha Sentiment Codex
PHR
PhreesiaANYSE / Health Care Equipment & Services
Last Price
Quote time unavailable
AI scenario view
RankAlpha Sentiment CodexMost likely
B
Base case
50%
Probability
Target price
$13.50
Analysis reference price unavailable
Analysis 2026-09-08 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$8.50
Analysis reference price unavailable
Analysis 2026-09-08 · RankAlpha Sentiment Codex
The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
Latest data as of 2026-09-08
Recent news sentiment (30D)
0.0
Mixed
Company
-
Unavailable
Macro
-
Unavailable
Pulse
-
Unavailable
Weekly research (10D)
+30.0
Positive
Sentiment proxy
+96.9
Score
AI commentary
The earnings follow-up is mixed: operating metrics, profitability, cash flow, debt reduction, and guidance were constructive, but forward visibility in Network Solutions remains limited. Social coverage and a complete post-print analyst-revision set are unavailable in the packet, so confidence remains moderate rather than high. The $10.94 anchor price is dated September 4, 2026.
RankAlpha Sentiment Codex - 2026-09-08
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-09-02eventQ2 FY2027 results and reaffirmed outlookHigh impact
Phreesia reported Q2 revenue of $129.5 million, up 10% year over year, adjusted EBITDA of $32.9 million, positive free cash flow of $13.8 million, and debt principal reduction of more than $23 million. FY2027 revenue and adjusted EBITDA outlooks were maintained at $510-$520 million and $125-$135 million, respectively. [#SEC-8K-2026-09-02]
2026-12-07catalystNetwork Solutions visibility and execution riskHigh impact
The company stated that Network Solutions revenue forecasting has greater variability, particularly in the second half of fiscal 2027. This creates downside risk to the maintained outlook if client adoption, pricing, or campaign activity underperforms. [#SEC-8K-2026-09-02]
2027-09-08catalystAccessOne and ProviderConnect monetizationHigh impact
Management identified AccessOne and ProviderConnect as products expected to drive future growth. FY2027 revenue guidance assumes approximately $37 million from AccessOne, while ProviderConnect remains an emerging Network Solutions opportunity. Execution and adoption remain unproven. [#SEC-8K-2026-09-02]
Recommendation
N/A
No formal recommendation provided.
As of 2026-09-08 • Updated nightlySource: Internal modelMethodology